StreetInsider.com Pre-Open Movers 12/24: (HLF) (NUS) (FB) Higher; (ALXA) (HOV) (AEGR) Lower (more...)
Tweet Send to a Friend
Get Alerts ALXA Hot Sheet
Up)
Trade ALXA Now!
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) 12% LOWER; FDA approved ADASUVE® (loxapine) Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. ADASUVE combines Alexza's proprietary Staccato® delivery system with the antipsychotic drug, loxapine. The Staccato system is a hand-held inhaler that delivers a drug aerosol to the deep lung that results in rapid systemic delivery and absorption of a drug. See below for Important Safety Information about ADASUVE, including Boxed Warnings.
Hovnanian Enterprises Inc. (NYSE: HOV) 5% LOWER; CEO sells large slug of stock
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) 3% LOWER; FDA approved JUXTAPID (lomitapide) capsules as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B) and non- high-density-lipoprotein cholesterol (non-HDL) in patients with homozygous familial hypercholesterolemia (HoFH).
Herbalife Ltd. (NYSE: HLF) 3% HIGHER; sets analyst meeting on January 10 in response to to short seller attack; says buyback exceeding plan,
Nu Skin Enterprises Inc. (NYSE: NUS) 3% HIGHER; bouncing with HLF
Facebook (NASDAQ: FB) 2% HIGHER; Needham & Company raised estimates and its price target citing strong mobile revenue growth and its scarcity value.
J. C. Penney Company, Inc. (NYSE: JCP) 2% HIGHER; positive comments about promotions at Oppenheimer.
Regions Financial Corp. (NYSE: RF) 2% LOWER; probed over improper loans - WSJ
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Hovnanian Enterprises Inc. (NYSE: HOV) 5% LOWER; CEO sells large slug of stock
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) 3% LOWER; FDA approved JUXTAPID (lomitapide) capsules as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B) and non- high-density-lipoprotein cholesterol (non-HDL) in patients with homozygous familial hypercholesterolemia (HoFH).
Herbalife Ltd. (NYSE: HLF) 3% HIGHER; sets analyst meeting on January 10 in response to to short seller attack; says buyback exceeding plan,
Nu Skin Enterprises Inc. (NYSE: NUS) 3% HIGHER; bouncing with HLF
Facebook (NASDAQ: FB) 2% HIGHER; Needham & Company raised estimates and its price target citing strong mobile revenue growth and its scarcity value.
J. C. Penney Company, Inc. (NYSE: JCP) 2% HIGHER; positive comments about promotions at Oppenheimer.
Regions Financial Corp. (NYSE: RF) 2% LOWER; probed over improper loans - WSJ
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- StreetInsider.com Pre-Open Movers 5/17: (HALO) (ORMP) (CLSN) Higher; (ARUN) (ADSK) (BRCD) Lower (more...)
- Streetinsider.com's Hot Lunchtime Reads 05/15: (HBC) (TSLA) (WTR) (BMY)
- Trading Radar for 05/16: Wal-mart (WMT), JCPenney (JCP), Applied Materials (AMAT), Autodesk (ADSK) Report
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Needham & Company
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
